FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...